Mepolizumab for severe eosinophilic asthma

Author： Robinson Douglas S  

Publisher： Informa Healthcare

ISSN： 1747-6348

Source： Expert Review of Respiratory Medicine, Vol.7, Iss.1, 2013-02, pp. : 13-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eosinophilic Esophagitis: Asthma of the Esophagus?

By  

Digestive Diseases, Vol. 32, Iss. 1-2, 2014-02 ,pp. : 54-60

Karger

Access to resources Recommend Favorite

Severe Asthma and Its Phenotype

By Wenzel Sally  

Journal of Asthma, Vol. 45, Iss. 1, 2008-01 ,pp. : 32-36

Informa Healthcare

Access to resources Recommend Favorite

Factors Associated With the Control of Severe Asthma

By Hermosa Juan Luis Rodriguez   Sánchez Carlos Barcina   Rubio Myriam Calle   Mínguez Mercedes Muñoz   Walther Jose Luis Alvarez-Sala  

Journal of Asthma, Vol. 47, Iss. 2, 2010-03 ,pp. : 124-130

Informa Healthcare

Access to resources Recommend Favorite

BAL Fluid 8-Isoprostane Concentrations in Eosinophilic Bronchitis and Asthma

By Xie Jiaxing   Zhang Qingling   Zhong Nanshan   Lai Kefang  

Journal of Asthma, Vol. 46, Iss. 7, 2009-09 ,pp. : 712-715

Informa Healthcare

Access to resources Recommend Favorite

Is a Single Blood Eosinophil Count a Reliable Marker for “Eosinophilic Asthma?”

By Spector Sheldon Laurence   Tan Ricardo Antonio  

Journal of Asthma, Vol. 49, Iss. 8, 2012-10 ,pp. : 807-810

Informa Healthcare

Access to resources Recommend Favorite